Search research articles
Contact Us
Filters
Showing results (51-60 of 81) with videos related to
Page
of 9
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology
|
December 21, 2018
Angiotensinogen and Megalin Interactions Contribute to Atherosclerosis-Brief Report
Feiming Ye, Ya Wang, Congqing Wu, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
June 7, 2019
Targeted Deletion of Hepatocyte Abca1 Increases Plasma HDL (High-Density Lipoprotein) Reverse Cholesterol Transport via the LDL (Low-Density Lipoprotein) Receptor
Alexander C Bashore, Mingxia Liu, Chia-Chi C Key, et al.
Cardiovascular Research
|
September 4, 2025
In PLN-R14del mice, SR structure restoration, rather than calcium cycling, is the dominant effector of PLN-ASO treatment
Liu Sun, Tim R Eijgenraam, Carl Amilon, et al.
Science Translational Medicine
|
December 1, 2021
Therapeutic inhibition of RBM20 improves diastolic function in a murine heart failure model and human engineered heart tissue
Michael H Radke, Victor Badillo-Lisakowski, Thiago Britto-Borges, et al.
Nucleic Acids Research
|
May 26, 2019
Fatty acid conjugation enhances potency of antisense oligonucleotides in muscle
Thazha P Prakash, Adam E Mullick, Richard G Lee, et al.
American Journal of Physiology. Heart and Circulatory Physiology
|
June 9, 2023
Chemerin is resident to vascular tunicas and contributes to vascular tone
Emma Wabel, Alexis Orr, Emma D Flood, et al.
Circulation Research
|
January 12, 2018
Novel Reversible Model of Atherosclerosis and Regression Using Oligonucleotide Regulation of the LDL Receptor
Debapriya Basu, Yunying Hu, Lesley-Ann Huggins, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
September 9, 2021
Renal Angiotensinogen Is Predominantly Liver Derived in Nonhuman Primates
Masayoshi Kukida, Lei Cai, Dien Ye, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
August 19, 2021
Deletion of AT1a (Angiotensin II Type 1a) Receptor or Inhibition of Angiotensinogen Synthesis Attenuates Thoracic Aortopathies in Fibrillin1<sup>C1041G/+</sup> Mice
Jeff Z Chen, Hisashi Sawada, Dien Ye, et al.
The Journal of Clinical Investigation
|
September 7, 2021
CREBH normalizes dyslipidemia and halts atherosclerosis in diabetes by decreasing circulating remnant lipoproteins
Masami Shimizu-Albergine, Debapriya Basu, Jenny E Kanter, et al.
Page
of 9
Search research articles
Search
Showing results (51-60 of 81) with videos related to
Sort By:
Page
of 9
Arteriosclerosis, Thrombosis, and Vascular Biology
|
December 21, 2018
Angiotensinogen and Megalin Interactions Contribute to Atherosclerosis-Brief Report
Feiming Ye, Ya Wang, Congqing Wu, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
June 7, 2019
Targeted Deletion of Hepatocyte Abca1 Increases Plasma HDL (High-Density Lipoprotein) Reverse Cholesterol Transport via the LDL (Low-Density Lipoprotein) Receptor
Alexander C Bashore, Mingxia Liu, Chia-Chi C Key, et al.
Cardiovascular Research
|
September 4, 2025
In PLN-R14del mice, SR structure restoration, rather than calcium cycling, is the dominant effector of PLN-ASO treatment
Liu Sun, Tim R Eijgenraam, Carl Amilon, et al.
Science Translational Medicine
|
December 1, 2021
Therapeutic inhibition of RBM20 improves diastolic function in a murine heart failure model and human engineered heart tissue
Michael H Radke, Victor Badillo-Lisakowski, Thiago Britto-Borges, et al.
Nucleic Acids Research
|
May 26, 2019
Fatty acid conjugation enhances potency of antisense oligonucleotides in muscle
Thazha P Prakash, Adam E Mullick, Richard G Lee, et al.
American Journal of Physiology. Heart and Circulatory Physiology
|
June 9, 2023
Chemerin is resident to vascular tunicas and contributes to vascular tone
Emma Wabel, Alexis Orr, Emma D Flood, et al.
Circulation Research
|
January 12, 2018
Novel Reversible Model of Atherosclerosis and Regression Using Oligonucleotide Regulation of the LDL Receptor
Debapriya Basu, Yunying Hu, Lesley-Ann Huggins, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
September 9, 2021
Renal Angiotensinogen Is Predominantly Liver Derived in Nonhuman Primates
Masayoshi Kukida, Lei Cai, Dien Ye, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology
|
August 19, 2021
Deletion of AT1a (Angiotensin II Type 1a) Receptor or Inhibition of Angiotensinogen Synthesis Attenuates Thoracic Aortopathies in Fibrillin1<sup>C1041G/+</sup> Mice
Jeff Z Chen, Hisashi Sawada, Dien Ye, et al.
The Journal of Clinical Investigation
|
September 7, 2021
CREBH normalizes dyslipidemia and halts atherosclerosis in diabetes by decreasing circulating remnant lipoproteins
Masami Shimizu-Albergine, Debapriya Basu, Jenny E Kanter, et al.
Page
of 9